INS and Hyperinsulinemia: Additionally, the improvement of glycemic control through SC insulin delivery does not come without a cost: individuals with T1D are exposed to peripheral non-physiologic hyperinsulinemia that, over time, is a major contributor to macrovascular complications, including hearth failure and macrovascular disease that are still three times more frequent in those with T1D respect to their healthy peers.